Cary J Claiborne
CIK 1370930 · Chief Executive Officer · last filed 2026-04-09
Cary J Claiborne is a Chief Executive Officer who has filed 43 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for ADIL, was dated Apr 9, 2026. Across all open-market trades the lifetime net is −$706.4K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $120.4K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$120.4K
6
43
-$706.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ADIL | Chief Executive Officer | 40,417 | $2.98 | $120.4K | $0 | 4 | 2026-04-09 |
| ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Chief Executive Officer | 1,520,000 | $0.00 | $1.4K | $0 | 6 | 2023-05-25 |
| Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Chief Financial Officer | 45,764 | — | — | -$734.6K | 18 | 2014-12-17 |
| New Generation Biofuels Holdings, Inc (NGBF) Delisted | CEO, CFO and President | 283,179 | — | — | $28.2K | 9 | 2009-12-29 |
| New Generation Biofuels Holdings, Inc (GNB) Delisted | Chief Financial Officer | 10,236 | — | — | $0 | 1 | 2008-06-06 |
| OSIRIS THERAPEUTICS, INC. (OSIR) Delisted | Chief Financial Officer | 75,000 | — | — | $0 | 3 | 2007-11-23 |
Recent Filings
43 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-09 | ADIL | Grant (A) | +37,985 | $0 | EDGAR |
| 2025-06-02 | ADIL | Grant (A) | — | $0 | EDGAR |
| 2024-12-05 | ADIL | Grant (A) | — | $0 | EDGAR |
| 2024-03-27 | ADIL | Grant (A) | — | $0 | EDGAR |
| 2024-01-29 | — | Grant (A) | — | $0 | |
| 2023-05-25 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Grant (A) | +420,000 | $0 | EDGAR |
| 2022-09-20 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Grant (A) | +100,000 | $42.2K | EDGAR |
| 2022-08-22 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Grant (A) | +1,000,000 | $0 | EDGAR |
| 2022-02-25 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-08 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Grant (A) | — | $0 | EDGAR |